Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology.
Clinical investigators in oncology are increasingly interested in using molecular analysis of cancer tissue to understand the biologic bases of response or resistance to novel interventions and to develop prognostic and predictive biomarkers that will guide clinical decision making. Some scientific questions of this nature can only be addressed, or may best be addressed, through the conduct of a clinical trial in which research biopsies are obtained from all participants. However, trial designs with mandatory research biopsies have raised ethical concerns related to the risk of harm to participants, the adequacy of voluntary informed consent, and the potential for misunderstanding among research participants when access to an experimental intervention is linked to the requirement to undergo a research biopsy. In consideration of the ethical and scientific issues at stake in this debate, the Cancer and Leukemia Group B Ethics Committee proposes guidelines for clinical trials involving mandatory research biopsies. Any cancer clinical trial that requires research biopsies of participants must be well designed to address the scientific question, obtain the biopsy in a way that minimizes risk, and ensure that research participants are fully informed of the risks, rationale, and requirements of the study, as well as of treatment alternatives. Further guidelines and discussions of this issue are specified in this position paper. We feel that if these principles are respected, an informed adult with cancer can both understand and voluntarily consent to participation in a clinical trial involving mandatory research biopsy for scientific end points.
Peppercorn
Jeffrey
J
Division of Medical Oncology, Duke University Medical Center, Durham, NC 27710, USA. jeffrey.peppercorn@duke.edu
Shapira
Iuliana
I
Collyar
Deborah
D
Deshields
Teresa
T
Lin
Nancy
N
Krop
Ian
I
Grunwald
Hans
H
Friedman
Paula
P
Partridge
Ann H
AH
Schilsky
Richard L
RL
Bertagnolli
Monica M
MM
D000328:Adult; D001706:Biopsy / Q000941:ethics* / Q000379:methods; D002986:Clinical Trials as Topic / Q000941:ethics* / Q000379:methods; D023381:Endpoint Determination / Q000941:ethics / Q000379:methods; D006801:Humans; D018580:Mandatory Testing / Q000941:ethics* / Q000379:methods; D008495:Medical Oncology / Q000941:ethics* / Q000379:methods
Eur Respir J. 2004 Sep;24(3):375-7
15358694
J Clin Oncol. 2004 Dec 1;22(23):4846-50
15570088
Breast Cancer Res Treat. 2009 Jan;113(2):207-9
18463974
J Clin Oncol. 2006 Oct 20;24(30):4793-5
17050863
J Clin Oncol. 1995 May;13(5):1062-72
7738612
JAMA. 2000 May 24-31;283(20):2701-11
10819955
Lancet. 2000 Aug 19;356(9230):635-8
10968436
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13520-5
18765795
N Engl J Med. 2009 May 14;360(20):2055-65
19439741
Clin Cancer Res. 2001 Oct;7(10):2971-6
11595684
Clin Cancer Res. 2008 Apr 15;14(8):2512; author reply 2513-4
18413847
J Natl Cancer Inst. 1988 Aug 17;80(12):886-7
3398065
N Engl J Med. 2001 Mar 15;344(11):783-92
11248153
J Clin Oncol. 2008 Aug 20;26(24):3987-94
18711189
Cancer J. 2002 Nov-Dec;8(6):461-8
12500855
N Engl J Med. 2008 Oct 23;359(17):1757-65
18946061
J Clin Oncol. 2008 Nov 20;26(33):5352-9
18955458
J Natl Cancer Inst. 2001 Jan 17;93(2):139-47
11208884
J Clin Oncol. 2008 Oct 1;26(28):4679-83
18662965
Cancer Cell. 2007 Oct;12(4):395-402
17936563
Annu Rev Med. 2008;59:429-42
17716025
Clin Trials. 2011 Oct;8(5):616-23
21813584
J Urol. 2006 May;175(5):1605-12
16600713
Ann Hematol. 2007 Feb;86(2):117-25
17031690
J Clin Oncol. 2007 Jul 20;25(21):3069-75
17634485
Gastrointest Endosc. 2009 Apr;69(4):906-10
19136110
Br J Cancer. 2005 Mar 28;92(6):1001-5
15770219
J Clin Oncol. 2008 Sep 10;26(26):4311-8
18779618
J Clin Oncol. 2009 Apr 20;27(12):2091-6
19188670
J Clin Oncol. 2007 Jul 1;25(19):2741-6
17602079
PLoS Med. 2007 Nov 27;4(11):e324
18044980
PLoS One. 2006 Dec 20;1:e98
17183730
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
18287387
J Clin Oncol. 2009 Aug 20;27(24):4027-34
19597023
N Engl J Med. 2003 Mar 13;348(11):994-1004
12637609
J Natl Compr Canc Netw. 2009 Jul;7 Suppl 4:S1-34, quiz S35-6
19635230
J Clin Oncol. 2004 Nov 1;22(21):4312-8
15514372
Science. 2004 Jan 16;303(5656):333
14726584
N Engl J Med. 2004 May 20;350(21):2129-39
15118073
J Clin Oncol. 2007 Apr 10;25(11):1454-5
17416872
J Am Coll Dent. 2014 Summer;81(3):4-13
25951677
Prostate. 2007 May 1;67(6):603-4
17290443
Cancer Invest. 2008 Feb;26(1):1-10
18181038
J Clin Oncol. 2006 Oct 20;24(30):4801-7
17050865